CohBar, Inc. Announces Third Quarter 2017 Financial Results
Nov 13, 2017 21:03 pm UTC| Business
MENLO PARK, Calif., Nov. 13, 2017 -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat...
Everspin Announces Third Quarter 2017 Financial Results
Nov 13, 2017 21:03 pm UTC| Business
CHANDLER, Ariz., Nov. 13, 2017 -- Everspin Technologies, Inc., (Nasdaq:MRAM), today announced the company’s third quarter 2017 financial results for the quarter ended September 30, 2017. Revenue for the third quarter...
ProQR Announces Proposed Public Offering of Ordinary Shares
Nov 13, 2017 21:01 pm UTC| Business
LEIDEN, the Netherlands, Nov. 13, 2017 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe...
Brooks Automation to Present at the Stifel 2017 Healthcare Conference
Nov 13, 2017 21:01 pm UTC| Business
CHELMSFORD, Mass., Nov. 13, 2017 -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the company will present at the Stifel 2017 Healthcare Conference at the Lotte New York Palace Hotel, New York. Steve...
TearLab Corporation Reports Third Quarter and September Year-To-Date 2017 Financial Results
Nov 13, 2017 21:01 pm UTC| Business
SAN DIEGO, Nov. 13, 2017 -- TearLab Corporation (OTCQB:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter and nine months ended September 30, 2017. All...
Famous Dave’s of America, Inc. Announces Private Placement
Nov 13, 2017 21:01 pm UTC| Business
MINNEAPOLIS, Nov. 13, 2017 -- Famous Dave’s of America, Inc. (NASDAQ:DAVE) (“Famous Dave’s” or the “Company”) today announced that it completed a private placement of 418,169 shares of its common stock at $3.50 per...
MacroGenics to Participate in Two Upcoming Investor Conferences
Nov 13, 2017 21:01 pm UTC| Business
ROCKVILLE, MD, Nov. 13, 2017 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment...
FxWirePro- Major Economic Events for the day